APA (7th ed.) Citation

Lee HY, Yang BM, Hong JM, Lee TJ, Kim BG, Kim JW, . . . Kang S. (2013). Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: Results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model. Dove Medical Press.

Chicago Style (17th ed.) Citation

Lee HY, Yang BM, Hong JM, Lee TJ, Kim BG, Kim JW, Kim YT, Kim YM, and Kang S. Cost–utility Analysis for Platinum-sensitive Recurrent Ovarian Cancer Therapy in South Korea: Results of the Polyethylene Glycolated Liposomal Doxorubicin/carboplatin Sequencing Model. Dove Medical Press, 2013.

MLA (9th ed.) Citation

Lee HY, et al. Cost–utility Analysis for Platinum-sensitive Recurrent Ovarian Cancer Therapy in South Korea: Results of the Polyethylene Glycolated Liposomal Doxorubicin/carboplatin Sequencing Model. Dove Medical Press, 2013.